Harvard Health Blog

New blood test may someday help guide the best treatment for aggressive prostate cancer

By: Charlie Schmidt, Editor, Harvard Medical School Annual Report on Prostate Disease Tumors that spread, or metastasize, in the body shed cells into blood that doctors can scrutinize for insights into what a patientís cancer might do. Analyzing these so-called circulating tumor cells (CTCs) isnít part of routine care yet, in part because theyíre so hard to pick out of the millions of normal cells in a blood sample. Still, scientists are making…

To continue reading this article you must be registered.

Get Licensed Content to Harvard Health

If you are interested in licensing content from Harvard Health Publications, please contact us using our online form. Our licensing and business development professionals will help you leverage consumer health content from Harvard Medical School as a clear differentiator in helping achieve your business goals.

Contact Us

Customer Log In